+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Angioplasty Balloons Market by Indication, Product, Type, End User - Global Forecast to 2030- Product Image
Angioplasty Balloons Market by Indication, Product, Type, End User - Global Forecast to 2030- Product Image
Sale

Angioplasty Balloons Market by Indication, Product, Type, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 198 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5665821
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Angioplasty Balloons Market grew from USD 4.14 billion in 2024 to USD 4.51 billion in 2025. It is expected to continue growing at a CAGR of 8.63%, reaching USD 6.80 billion by 2030.

Setting the Stage for the Next Frontier in Angioplasty Balloons

Angioplasty balloons have emerged as indispensable tools in the management of vascular occlusions and stenosis, transforming the clinical approach to coronary and peripheral interventions. Recent advances in balloon material science, drug delivery coatings, and delivery system precision have accelerated procedural success rates and patient outcomes. As the global healthcare landscape adapts to demographic shifts and rising cardiovascular disease prevalence, angioplasty balloons are at the forefront of minimally invasive therapy. This executive summary provides a nuanced exploration of the forces shaping the market, the challenges posed by international trade policies, and the innovation pathways driving future growth.

By examining technological breakthroughs alongside evolving stakeholder needs, this introduction sets the stage for a comprehensive assessment of the angioplasty balloon sector. It emphasizes the interplay between regulatory frameworks, reimbursement environments, and clinical evidence generation. Stakeholders, from device manufacturers to healthcare providers, must navigate a complex ecosystem where product differentiation hinges on safety, deliverability, and long-term vessel patency. The ensuing sections delve into landscape shifts, tariff implications, segmentation nuances, regional dynamics, competitive positioning, and strategic recommendations, guiding decision-makers toward informed actions in this dynamic market.

Paradigm Shifts Redefining Angioplasty Balloon Dynamics

The angioplasty balloon market is witnessing transformative shifts spurred by converging technological, regulatory, and clinical trends. Novel polymer blends and hybrid balloon architectures have enhanced compliance and radial force control, enabling more precise lesion preparation and drug delivery. Concurrently, the growing body of long-term clinical data is reshaping physician preferences, with a clear tilt toward drug-coated solutions that mitigate restenosis risk. Regulatory agencies worldwide are harmonizing standards for safety and performance, streamlining approval pathways while raising the bar for post-market surveillance.

In parallel, digital integration is redefining product development and procedural planning. Artificial intelligence-driven imaging analytics now inform balloon selection and inflation protocols, optimizing outcomes and reducing procedure times. Furthermore, value-based healthcare models are compelling providers to consider total cost of care, elevating the importance of durable efficacy and reduced readmission rates. These shifts collectively underscore a market in flux, where agility, clinical validation, and data transparency are paramount for companies striving to lead the next wave of angioplasty balloon innovation.

Evaluating the 2025 US Tariffs and Their Market Reverberations

The imposition of new tariffs by the United States in 2025 has created reverberations across the angioplasty balloon supply chain and cost structures. Import duties on critical balloon components and finished devices have elevated landed costs, prompting manufacturers to re-evaluate sourcing strategies. In response, many producers are considering near-shoring and diversification of component procurement to mitigate exposure to tariff fluctuations and safeguard margins.

Clinicians and healthcare systems are feeling the impact through procurement negotiations and budgetary constraints, driving a renewed focus on cost-effectiveness analyses. Pricing pressures have intensified competition among suppliers, leading to increased promotional activity and bundled offering arrangements. Meanwhile, upstream suppliers of polymers and coatings are reassessing their market positioning to align with shifting demand patterns. Ultimately, the cumulative effect of these trade measures is catalyzing a strategic realignment within the global angioplasty balloon ecosystem, where resilience and supply chain agility have become critical competitive differentiators.

Deep Dive into Indication, Product, Type, and End User Segmentation

A holistic understanding of angioplasty balloon market segmentation reveals critical insights across clinical application, product characteristics, device type, and end-user environment. Within clinical application, coronary interventions remain the primary revenue driver, while peripheral segments are experiencing accelerated growth in carotid, iliac, lower limb, and renal interventions as physicians expand minimally invasive treatment protocols beyond cardiac care. On the product front, plain balloons continue to serve as essential lesion preparation tools, but drug-coated variants, particularly those utilizing paclitaxel and sirolimus coatings, now capture significant market share due to their proven efficacy in restenosis prevention.

Device type also plays a pivotal role in procedure selection. Compliant balloons offer flexibility in vessel sizing, cutting and scoring balloons facilitate precise plaque modification, and non-compliant and semi-compliant balloons deliver controlled radial force for optimal lumen expansion. Scoring balloons, with their microblades, address particularly fibrotic lesions, demonstrating the importance of tailored device mechanics. Finally, the end-user landscape ranges from ambulatory surgical centers and specialist cardiac centers to hospitals and specialty clinics. Within hospitals, private and public institutions vary in procurement cycles and budget frameworks, influencing adoption rates and reimbursement negotiations. By synthesizing these segmentation dimensions, stakeholders can align product development and marketing strategies with evolving clinical and operational requirements.

Navigating Regional Landscapes from Americas to Asia-Pacific

Regional dynamics exert profound influence on angioplasty balloon demand, reimbursement environments, and regulatory pathways. In the Americas, the combination of well-established reimbursement frameworks and robust clinical trial activity fosters rapid adoption of next-generation balloons. Market consolidation among distributors and increased private-public partnership models underscore the region’s focus on cost containment and quality outcomes. Europe, the Middle East & Africa present a mosaic of markets: Western European nations benefit from uniform regulatory standards and strong hospital purchasing power, while emerging markets prioritize affordability and infrastructure development. The Gulf region’s investment in healthcare modernization and Africa’s growing interventional cardiology capacity highlight opportunities for market expansion.

Asia-Pacific remains a dynamic frontier, driven by rising cardiovascular disease incidence, expanding healthcare infrastructure, and evolving patient access programs. Countries such as Japan and Australia serve as innovation hubs with advanced clinical research capabilities, whereas markets like India and Southeast Asia emphasize high-volume, cost-effective device adoption. Strategic collaborations between global manufacturers and local entities are instrumental in navigating diverse regulatory landscapes and distribution networks across this multifaceted region.

Competitive Landscape and Innovator Profiles Shaping the Market

Leading players in the angioplasty balloon market are distinguishing themselves through targeted investments in R&D, strategic alliances, and portfolio expansion. Established medical device conglomerates continue to leverage broad cardiovascular portfolios to integrate balloon technologies with imaging and delivery systems. Meanwhile, specialized innovators are focusing on niche applications, such as high-precision scoring balloons and bioresorbable coatings, to capture dedicated market segments. Collaborative partnerships between device developers and pharmaceutical companies are accelerating the laboratory-to-clinic transition of novel drug-eluting balloons, enhancing both safety profiles and therapeutic efficacy.

Mergers and acquisitions remain a key mechanism for scaling capabilities and expanding geographic reach. Recent deals have demonstrated an appetite for acquiring companies with proprietary coating technologies or differentiated balloon materials. Additionally, joint ventures with regional distributors are optimizing market entry and establishing localized manufacturing hubs. These strategic maneuvers underscore a competitive environment where technological leadership and global footprint are essential to sustaining growth in the angioplasty balloon sector.

Strategic Imperatives for Angioplasty Balloon Market Leaders

To thrive in this rapidly evolving environment, industry leaders should prioritize a dual focus on innovation and operational resilience. Companies must accelerate development of next-generation coatings and device architectures that address emerging clinical needs, while also fortifying their supply chains through diversified sourcing and near-shoring initiatives. Leveraging real-world evidence and health economics data will be crucial to demonstrating value in a value-based care paradigm and securing favorable reimbursement terms.

Furthermore, fostering collaborative ecosystems that bring together device engineers, clinical experts, and data scientists can expedite iterative improvements and co-develop user-centric solutions. Market entrants and incumbents alike should explore strategic alliances with regional partners to navigate complex regulatory landscapes and expedite market access. Finally, embedding digital service offerings-such as remote monitoring and procedure analytics-can enhance customer engagement and strengthen long-term relationships with healthcare providers.

Robust Research Framework Underpinning Market Insights

This analysis is underpinned by a rigorous research framework that combines comprehensive secondary research with primary qualitative engagements. Key industry reports, regulatory filings, and peer-reviewed clinical studies were systematically reviewed to establish baseline market characteristics and identify emerging trends. To validate and enrich these findings, in-depth interviews were conducted with interventional cardiologists, vascular surgeons, procurement specialists, and supply chain executives across major markets.

Data triangulation techniques were applied to reconcile discrepancies and ensure analytical consistency. Market dynamics were further stress-tested through scenario analysis, incorporating potential regulatory changes, tariff adjustments, and technology adoption curves. Throughout the process, methodological rigor was maintained via a structured quality assurance protocol, including stakeholder reviews and benchmarking against third-party data sources. This multifaceted approach provides stakeholders with a robust, evidence-based foundation for strategic decision-making in the angioplasty balloon domain.

Synthesis of Insights Driving Future Angioplasty Balloon Strategies

The angioplasty balloon sector stands at an inflection point, driven by technological breakthroughs, evolving policy landscapes, and shifting clinical practices. As tariff pressures reshape supply chains, companies must adapt through agile sourcing and value-based positioning. Segmentation insights underscore the importance of targeted solutions across indications, product types, and end-user environments, while regional analyses reveal diverse growth trajectories and adoption frameworks.

Leading firms are differentiating through strategic partnerships, cutting-edge R&D investments, and global expansion efforts. Moving forward, success will hinge on a balanced approach that combines clinical validation, digital integration, and collaborative innovation ecosystems. By synthesizing market dynamics with actionable intelligence, stakeholders can chart a course toward sustained growth and improved patient outcomes in the rapidly advancing world of angioplasty balloons.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Indication
    • Coronary
    • Peripheral
      • Carotid
      • Iliac
      • Lower Limb
      • Renal
  • Product
    • Drug Coated Balloon
      • Paclitaxel Coated
      • Sirolimus Coated
    • Plain Balloon
  • Type
    • Compliant
    • Cutting Balloon
    • Non Compliant
    • Scoring Balloon
    • Semi Compliant
  • End User
    • Ambulatory Surgical Centers
    • Cardiac Centers
    • Hospitals
      • Private
      • Public
    • Specialty Clinics
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Medtronic plc
  • Becton, Dickinson and Company
  • Terumo Corporation
  • Cordis Corporation
  • Cook Medical LLC
  • Nipro Corporation
  • OrbusNeich Medical Company Ltd.
  • LeMaitre Vascular, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Angioplasty Balloons Market, by Indication
8.1. Introduction
8.2. Coronary
8.3. Peripheral
8.3.1. Carotid
8.3.2. Iliac
8.3.3. Lower Limb
8.3.4. Renal
9. Angioplasty Balloons Market, by Product
9.1. Introduction
9.2. Drug Coated Balloon
9.2.1. Paclitaxel Coated
9.2.2. Sirolimus Coated
9.3. Plain Balloon
10. Angioplasty Balloons Market, by Type
10.1. Introduction
10.2. Compliant
10.3. Cutting Balloon
10.4. Non Compliant
10.5. Scoring Balloon
10.6. Semi Compliant
11. Angioplasty Balloons Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Cardiac Centers
11.4. Hospitals
11.4.1. Private
11.4.2. Public
11.5. Specialty Clinics
12. Americas Angioplasty Balloons Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Angioplasty Balloons Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Angioplasty Balloons Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Boston Scientific Corporation
15.3.2. Abbott Laboratories
15.3.3. Medtronic plc
15.3.4. Becton, Dickinson and Company
15.3.5. Terumo Corporation
15.3.6. Cordis Corporation
15.3.7. Cook Medical LLC
15.3.8. Nipro Corporation
15.3.9. OrbusNeich Medical Company Ltd.
15.3.10. LeMaitre Vascular, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ANGIOPLASTY BALLOONS MARKET MULTI-CURRENCY
FIGURE 2. ANGIOPLASTY BALLOONS MARKET MULTI-LANGUAGE
FIGURE 3. ANGIOPLASTY BALLOONS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ANGIOPLASTY BALLOONS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ANGIOPLASTY BALLOONS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ANGIOPLASTY BALLOONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CORONARY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CAROTID, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY ILIAC, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY LOWER LIMB, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY RENAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PACLITAXEL COATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY SIROLIMUS COATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PLAIN BALLOON, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY COMPLIANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CUTTING BALLOON, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY NON COMPLIANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY SCORING BALLOON, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY SEMI COMPLIANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PRIVATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY PUBLIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES ANGIOPLASTY BALLOONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 50. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 51. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 52. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 54. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. CANADA ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 57. MEXICO ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 58. MEXICO ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 59. MEXICO ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. MEXICO ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 61. MEXICO ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. MEXICO ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. MEXICO ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 86. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 87. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 88. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 90. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. UNITED KINGDOM ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 93. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 94. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 95. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 97. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. GERMANY ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 100. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 101. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 102. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 104. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. FRANCE ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 107. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 108. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 109. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 111. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. RUSSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 114. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 115. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 116. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 118. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. ITALY ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 121. SPAIN ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 122. SPAIN ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 123. SPAIN ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. SPAIN ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 125. SPAIN ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 126. SPAIN ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. SPAIN ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 128. UNITED ARAB EMIRATES ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 129. UNITED ARAB EMIRATES ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 130. UNITED ARAB EMIRATES ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. UNITED ARAB EMIRATES ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 132. UNITED ARAB EMIRATES ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. UNITED ARAB EMIRATES ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. UNITED ARAB EMIRATES ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 135. SAUDI ARABIA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 136. SAUDI ARABIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 137. SAUDI ARABIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. SAUDI ARABIA ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 139. SAUDI ARABIA ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. SAUDI ARABIA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. SAUDI ARABIA ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 142. SOUTH AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 143. SOUTH AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 144. SOUTH AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. SOUTH AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 146. SOUTH AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 147. SOUTH AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. SOUTH AFRICA ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 149. DENMARK ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 150. DENMARK ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 151. DENMARK ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 152. DENMARK ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 153. DENMARK ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 154. DENMARK ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. DENMARK ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 156. NETHERLANDS ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 157. NETHERLANDS ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 158. NETHERLANDS ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 159. NETHERLANDS ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 160. NETHERLANDS ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 161. NETHERLANDS ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. NETHERLANDS ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 163. QATAR ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 164. QATAR ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 165. QATAR ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 166. QATAR ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 167. QATAR ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 168. QATAR ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. QATAR ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 170. FINLAND ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 171. FINLAND ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 172. FINLAND ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 173. FINLAND ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 174. FINLAND ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 175. FINLAND ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. FINLAND ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 182. SWEDEN ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. SWEDEN ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 184. NIGERIA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 185. NIGERIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 186. NIGERIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 187. NIGERIA ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 188. NIGERIA ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 189. NIGERIA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. NIGERIA ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 191. EGYPT ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 192. EGYPT ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 193. EGYPT ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 194. EGYPT ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 195. EGYPT ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 196. EGYPT ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. EGYPT ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 198. TURKEY ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 199. TURKEY ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 200. TURKEY ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 201. TURKEY ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 202. TURKEY ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 203. TURKEY ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. TURKEY ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 205. ISRAEL ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 206. ISRAEL ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 207. ISRAEL ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 208. ISRAEL ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 209. ISRAEL ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 210. ISRAEL ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. ISRAEL ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 212. NORWAY ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 213. NORWAY ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 214. NORWAY ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 215. NORWAY ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 216. NORWAY ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 217. NORWAY ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. NORWAY ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 219. POLAND ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 220. POLAND ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 221. POLAND ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 222. POLAND ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 223. POLAND ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 224. POLAND ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. POLAND ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 226. SWITZERLAND ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 227. SWITZERLAND ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 228. SWITZERLAND ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 229. SWITZERLAND ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 230. SWITZERLAND ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 231. SWITZERLAND ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. SWITZERLAND ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 233. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 234. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 241. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 242. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 243. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 244. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 245. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 246. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. CHINA ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 248. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 249. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 250. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 251. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 252. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 253. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 254. INDIA ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 255. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 256. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 257. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 258. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 259. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 260. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. JAPAN ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 262. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 267. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 268. AUSTRALIA ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 269. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 270. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 271. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 272. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 273. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 274. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 276. INDONESIA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 277. INDONESIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 281. INDONESIA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. INDONESIA ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 283. THAILAND ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 284. THAILAND ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 285. THAILAND ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 286. THAILAND ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 287. THAILAND ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 288. THAILAND ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. THAILAND ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 290. PHILIPPINES ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 291. PHILIPPINES ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 292. PHILIPPINES ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 293. PHILIPPINES ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 294. PHILIPPINES ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 295. PHILIPPINES ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 296. PHILIPPINES ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 297. MALAYSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 298. MALAYSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 299. MALAYSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 302. MALAYSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 303. MALAYSIA ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 304. SINGAPORE ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 305. SINGAPORE ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 306. SINGAPORE ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 307. SINGAPORE ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 308. SINGAPORE ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 309. SINGAPORE ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 310. SINGAPORE ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 311. VIETNAM ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 312. VIETNAM ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 313. VIETNAM ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 314. VIETNAM ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 315. VIETNAM ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 316. VIETNAM ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 317. VIETNAM ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 318. TAIWAN ANGIOPLASTY BALLOONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 319. TAIWAN ANGIOPLASTY BALLOONS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 320. TAIWAN ANGIOPLASTY BALLOONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 321. TAIWAN ANGIOPLASTY BALLOONS MARKET SIZE, BY DRUG COATED BALLOON, 2018-2030 (USD MILLION)
TABLE 322. TAIWAN ANGIOPLASTY BALLOONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 323. TAIWAN ANGIOPLASTY BALLOONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 324. TAIWAN ANGIOPLASTY BALLOONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 325. ANGIOPLASTY BALLOONS MARKET SHARE, BY KEY PLAYER, 2024
TABLE 326. ANGIOPLASTY BALLOONS MARKET, FPNV POSITIONING MATRIX, 2024

Companies Mentioned

The companies profiled in this Angioplasty Balloons market report include:
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Medtronic plc
  • Becton, Dickinson and Company
  • Terumo Corporation
  • Cordis Corporation
  • Cook Medical LLC
  • Nipro Corporation
  • OrbusNeich Medical Company Ltd.
  • LeMaitre Vascular, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages198
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 4.51 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.8 Billion
Compound Annual Growth Rate8.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Angioplasty Balloons Market Size, Share & Trends Analysis Report By Product, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Angioplasty Balloons Market Size, Share & Trends Analysis Report By Product, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Angioplasty Balloons And Stents - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Angioplasty Balloons And Stents - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Angioplasty Balloon Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Angioplasty Balloon Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 86 Pages
  • Global
From
Angioplasty Balloons Market Report by Product Type, Application, Material, End-User, and Region 2024-2032 - Product Image

Angioplasty Balloons Market Report by Product Type, Application, Material, End-User, and Region 2024-2032

  • Report
  • 135 Pages
  • Global
From
Angioplasty Balloons - Global Strategic Business Report - Product Image

Angioplasty Balloons - Global Strategic Business Report

  • Report
  • 193 Pages
  • Global
From

About the Angioplasty Balloon Market

The Angioplasty Balloon market is a segment of the Cardiovascular Devices industry. It is composed of medical devices used to open blocked or narrowed arteries and veins. Angioplasty balloons are typically inserted into the body through a catheter and inflated to widen the vessel. The procedure is often used to treat coronary artery disease, peripheral artery disease, and other conditions. The Angioplasty Balloon market is highly competitive, with a variety of manufacturers offering a range of products. Companies in the market include Boston Scientific, Medtronic, Abbott, B. Braun, and Terumo. These companies offer a range of products, including balloons, catheters, and other accessories. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.